Aguanta, Beverly C.

HRN: 12-30-48  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/10/2023
AZITHROMYCIN 500MG TABLET (TAB)
01/10/2023
01/14/2023
PO
500mg
OD
CAP MR
Waiting Final Action 
01/10/2023
CEFTRIAXONE 1G (VIAL)
01/10/2023
01/17/2023
IV
2g
OD
CAP MR
Waiting Final Action 
01/21/2023
LEVOFLOXACIN 500MG (TAB)
01/21/2023
01/27/2023
PO
500mg Tab
OD
Pneumonja
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: